KODKodiak Sciences Inc Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 17783
Ticker: KOD
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-10-04
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: KOD

Detail

Enriched 2026-08-14 20:47

Market cap: $2,716,530,123.81
Shares outstanding (class): 62,578,441
Shares outstanding (weighted): 62,578,441
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 124
Location: PALO ALTO, CA
Homepage: https://www.kodiak.com
Description: Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.

Market cap and share counts drift.

Funds holding this security

112 funds · 114 positions · $316.04M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$51.24M	0.69%	1,344,151 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$46.76M	0.00%	1,226,542 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$35.14M	0.05%	921,740 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$35.13M	0.32%	921,511 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$17.12M	0.02%	449,070 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$16.10M	0.20%	422,431 NS	FIGI
Artisan International Small-Mid Fund Artisan Partners Funds Inc.	—	$15.55M	0.58%	407,931 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$12.36M	0.10%	324,241 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$10.28M	0.08%	269,644 NS	FIGI
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$9.55M	0.10%	250,594 NS	FIGI
T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC.	—	$6.90M	0.09%	180,883 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$6.89M	0.08%	180,800 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$5.87M	0.14%	153,977 NS	FIGI
BRUCE FUND Bruce Fund, Inc.	—	$5.53M	1.53%	145,000 NS	FIGI
T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc.	—	$3.77M	0.09%	98,874 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERKOD
FIGI_COMPOSITEBBG00BVR0D02
FIGI_SHARE_CLASSBBG00BVR0D11
CIK0001468748
ISINUS50015M1099
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Kodiak Sciences is a biopharmaceutical company developing treatments for retinal diseases, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.